Nicotine Patch - Bioequivalence Study

PHASE1CompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions
Healthy Smokers
Interventions
DRUG

Test treatment : V0116 transdermal patch

DRUG

Reference treatment : Nicotine transdermal patch

Trial Locations (1)

38610

Gières

All Listed Sponsors
lead

Pierre Fabre Medicament

INDUSTRY

NCT02089308 - Nicotine Patch - Bioequivalence Study | Biotech Hunter | Biotech Hunter